Your Search Results

CTO-PCI in patients with reduced left-ventricular function

18 May 2023 – From EuroPCR 2023

Discover the management strategies for CTO-PCI in patients with reduced left-ventricular function in this session: witness the utilization of ECMO protection during CTO PCI in the presence of electrical instability, encounter the complexities of multivessel PCI in the setting of severe left ventricular systolic dysfunction, explore the...

Valve-in-valve procedures - Part 2

18 May 2023 – From EuroPCR 2023

Embark on a captivating exploration of a challenging valve-in-valve case, where a non-retractable self-expandable aortic prosthetic valve presents a unique complication by deeply opening within the left ventricle, and witness the successful management of this complex scenario.

Unusual NSTEMI

18 May 2023 – From EuroPCR 2023

Embark on an exploration of unusual NSTEMI cases, where extraordinary interventions and innovative approaches redefine patient care: witness the life-saving use of ECMO in acute coronary occlusion and cardiac arrest, delve into the complexities of multivessel PCI in patients with global vascular disease and renal dysfunction,...

EuroPCR 2023 Hotlines/Late-Breaking Trials: from (N)STEMI to Chronic Coronary Syndromes (CCS)

19 May 2023 – From EuroPCR 2023

What are the most significant facts in this respect? Get the essentials by listening to the presenters review some clinical hotlines. To cite a few, Selective Intracoronary hypothermia in anterior wall myocardial infarction; real-time catheter-based microvascular obstruction detection in STEMI : results from the MOCCA I...

from (N)STEMI to Chronic Coronary Syndromes (CCS)

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

01 Aug 2025

The CLEAR SYNERGY (OASIS 9) Trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone versus placebo in patients with myocardial infarction

18 Nov 2024

Mirvat Alasnag provides her take on the CLEAR SYNERGY trial presented by Sanjit S Jolly at AHA 2024 in Chicago.